Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 82151-82200 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05455112
Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis
PHASE2Recruiting
44 participants
Started: Oct 29, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor2 locations
NCT05605613
PD-1 Antibody in Addition to BACE in Patients With NSCLC: A Randomised Controlled Trial
PHASE2/PHASE3Recruiting
150 participants
Started: Oct 29, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor8 locations
NCT05613686
Theta Burst Stimulation for Motor Recovery
NARecruiting
60 participants
Started: Oct 29, 2022 · Completed: Oct 29, 2024
1 condition1 sponsor1 location
NCT05348863
SPARK- a Digital Platform to Improve Self-management of Gestational Diabetes
NARecruiting
360 participants
Started: Oct 28, 2022 · Completed: Dec 30, 2026
1 condition3 sponsors1 location
NCT06317948
Improving the Quality of Radiotherapy by Multi-Institution Knowledge-Based Planning Optimization Models (Acronym: MIKAPOCo, Multi-Institutional Knowledge-based Approach in Plan Optimization for the Community)
N/AEnrolling by invitation
1,000 participants
Started: Oct 28, 2022 · Completed: Oct 28, 2025
2 conditions1 sponsor1 location
NCT05394259
A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer
PHASE1Recruiting
36 participants
Started: Oct 28, 2022 · Completed: Feb 2, 2027
3 conditions2 sponsors1 location
NCT05615714
Paresthesia-free Peripheral Nerve Field Stimulation for Trigeminal Neuralgia (FreeST Trial)
PHASE1/PHASE2Recruiting
24 participants
Started: Oct 28, 2022 · Completed: Oct 28, 2024
2 conditions1 sponsor2 locations
NCT05508633
The Instant Efficacy and Safety of Alverine in Decreasing Portal Hypertension: an Exploratory Pilot Study
PHASE2Enrolling by invitation
20 participants
Started: Oct 28, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05131672
Cast or Operation for Medial Epicondyle Fracture Treatment in Children
NARecruiting
334 participants
Started: Oct 28, 2022 · Completed: Aug 31, 2028
1 condition2 sponsors1 location
NCT05582265
Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Neck Squamous Cell Carcinoma (REDUCTION-I)
PHASE3Recruiting
537 participants
Started: Oct 28, 2022 · Completed: Oct 31, 2030
1 condition3 sponsors3 locations
NCT05561907
Enteral Anastomosis for the Treatment of Gastric Outlet Obstruction: A Randomized Controlled Study Comparing Endoscopic Versus Surgical Gastrojejunostomy
NARecruiting
32 participants
Started: Oct 28, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor3 locations
NCT06514482
Spanish Registry of Patients With Sleep Apnea and Daytime Sleepiness
N/ARecruiting
1,000 participants
Started: Oct 28, 2022 · Completed: Oct 28, 2025
1 condition1 sponsor1 location
NCT05827848
Evaluate the Safety and Efficacy of a Peripheral Nerve Stimulation
NARecruiting
62 participants
Started: Oct 28, 2022 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT05396859
Entrectinib in Combination With ASTX727 for the Treatment of Relapsed/Refractory TP53 Mutated Acute Myeloid Leukemia
PHASE1Active, not recruiting
13 participants
Started: Oct 28, 2022 · Completed: Jun 30, 2026
3 conditions4 sponsors1 location
NCT05563961
A Partial Randomized, Single-blind or Open-label, Dose-escalation With Multiple-dose Design Study to Evaluate the Pharmacokinetics of Acetaminophen and Its Toxic Metabolites With Panadol® and SafeTynadol® in Healthy Volunteers
NARecruiting
48 participants
Started: Oct 28, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05677282
Single Dose Antibiotic Treatment of Acute Watery Diarrhea, Rifaximin Versus Azithromycin, With Loperamide Adjunct
PHASE4Recruiting
150 participants
Started: Oct 28, 2022 · Completed: Dec 31, 2025
2 conditions3 sponsors4 locations
NCT05529108
Glycaemic Control Effect of BSG and Underlying Gut - Related Mechanism in Singapore Adults With Metabolic Syndrome
NAActive, not recruiting
38 participants
Started: Oct 28, 2022 · Completed: Sep 30, 2024
2 conditions2 sponsors1 location
NCT05389449
A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH
PHASE3Active, not recruiting
80 participants
Started: Oct 28, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor45 locations
NCT06224062
Virus and Bronchial Epithelium in Children and the Elderly
NARecruiting
200 participants
Started: Oct 28, 2022 · Completed: Apr 28, 2025
1 condition1 sponsor1 location
NCT03952962
Tractography Guided Subcallosal Cingulate Deep Brain Stimulation for Treatment Resistant Depression
NARecruiting
12 participants
Started: Oct 28, 2022 · Completed: Jul 31, 2027
2 conditions1 sponsor1 location
NCT05562271
Clinical Trial of Low-dose Radiation Therapy in Patients With Knee Osteoarthritis (LoRD-KNeA Trial)
NAActive, not recruiting
114 participants
Started: Oct 28, 2022 · Completed: Sep 30, 2025
1 condition4 sponsors3 locations
NCT06073418
Dietary Habits, Nutritional Knowledge and Physical Activity Assessment in Early Stage Breast Cancer Patients
N/ARecruiting
1,098 participants
Started: Oct 28, 2022 · Completed: Jul 1, 2032
1 condition1 sponsor1 location
NCT04867187
rTMS Efficacy Coupled With Mirror Therapy
NARecruiting
64 participants
Started: Oct 27, 2022 · Completed: Apr 30, 2027
1 condition1 sponsor2 locations
NCT05238740
Comparison of Radiographic Fusion Rate and Clinical Outcome of ALIF and XLIF Performed With Either Recombinant Human Bone Morphogenetic Protein-2 or ViviGen®
NARecruiting
168 participants
Started: Oct 27, 2022 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT05602259
PROspective Trial on EOsinophilia in Non-Small Cell Lung Cancer (NSCLC).
NARecruiting
200 participants
Started: Oct 27, 2022 · Completed: May 1, 2025
1 condition1 sponsor1 location
NCT07183020
Kappa Free Light Chains (KFLC) in Multiple Sclerosis (MS) and Clinically Isolated Syndrome (CIS)
N/AEnrolling by invitation
1,142 participants
Started: Oct 27, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05686525
Clinical Trial on the Effectiveness of TUMT Compared to PAE in Reducing Severe LUTS in Men with BPH
NARecruiting
220 participants
Started: Oct 27, 2022 · Completed: Dec 31, 2030
2 conditions2 sponsors3 locations
NCT05452941
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
N/ARecruiting
12,500 participants
Started: Oct 27, 2022 · Completed: Jun 4, 2027
1 condition1 sponsor91 locations
NCT05334979
Oxalate and Citrate
NARecruiting
50 participants
Started: Oct 27, 2022 · Completed: Oct 1, 2025
2 conditions1 sponsor1 location
NCT05534932
Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women
NARecruiting
70 participants
Started: Oct 27, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05784142
Chemo-immunotherapy Induction Followed by Hypo-radiotherapy in LA-NSCLC(CHIC)
PHASE2Active, not recruiting
55 participants
Started: Oct 27, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT04790253
PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
NARecruiting
600 participants
Started: Oct 27, 2022 · Completed: Apr 30, 2028
2 conditions2 sponsors41 locations
NCT05364892
Biocollection of Patients With ANCA Associated Vasculitis
NARecruiting
100 participants
Started: Oct 27, 2022 · Completed: Oct 27, 2032
1 condition1 sponsor1 location
NCT05601193
Ovarian PRP Injection in Women With POR
NARecruiting
390 participants
Started: Oct 27, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05626504
Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms
N/AActive, not recruiting
50 participants
Started: Oct 27, 2022 · Completed: Mar 31, 2025
3 conditions1 sponsor1 location
NCT05434156
ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With Depression
PHASE1/PHASE2Active, not recruiting
84 participants
Started: Oct 27, 2022 · Completed: Mar 31, 2026
3 conditions2 sponsors2 locations
NCT05522231
Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2)
PHASE2/PHASE3Active, not recruiting
265 participants
Started: Oct 27, 2022 · Completed: Mar 31, 2025
1 condition1 sponsor48 locations
NCT05578690
Healthy Lifestyle Before and During Pregnancy to Prevent Childhood Obesity - the PRE-STORK-trial
NARecruiting
360 participants
Started: Oct 26, 2022 · Completed: Jul 31, 2029
2 conditions2 sponsors1 location
NCT05038683
Holbæk Obesity Treatment (HOT) Versus Conventional Obesity Treatment (COT) in Children With Overweight or Obesity.
NARecruiting
554 participants
Started: Oct 26, 2022 · Completed: Jan 31, 2027
1 condition9 sponsors5 locations
NCT05554120
The Next Step in Smoking Prevention: the Reduction of Tobacco Retail Outlets, a Comprehensive Policy Evaluation
N/AEnrolling by invitation
1,450 participants
Started: Oct 26, 2022 · Completed: May 31, 2026
4 conditions4 sponsors1 location
NCT04937998
PRP Versus HA IN OSTEOARTHRITIS OF THE PATELLOFEMORAL JOINT
NARecruiting
166 participants
Started: Oct 26, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05417932
A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
PHASE1/PHASE2Recruiting
46 participants
Started: Oct 26, 2022 · Completed: Oct 31, 2025
2 conditions1 sponsor6 locations
NCT05906914
Cladribine Plus Homoharringtonine and Cytarabine Regimen (CHA) for de Novo Acute Myeloid Leukemia
PHASE2Recruiting
30 participants
Started: Oct 26, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05451771
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
PHASE1/PHASE2Recruiting
53 participants
Started: Oct 26, 2022 · Completed: Sep 30, 2026
1 condition2 sponsors4 locations
NCT05613751
Enhancing Protection Against Influenza and COVID-19 for Pregnant Women and Medically at Risk Children
NARecruiting
1,038 participants
Started: Oct 26, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor7 locations
NCT05809388
Virtual Reality for Parent Training Intervention
NARecruiting
68 participants
Started: Oct 26, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05111925
Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty Enhancement
N/ARecruiting
2,690 participants
Started: Oct 26, 2022 · Completed: May 31, 2025
1 condition3 sponsors2 locations
NCT05132517
Magnesium and Cognition After Stroke
N/ARecruiting
80 participants
Started: Oct 26, 2022 · Completed: Sep 30, 2026
4 conditions1 sponsor1 location
NCT05454527
Follow-up of Patients With Inflammatory Myopathies Associated With a Biobank
N/ARecruiting
4,000 participants
Started: Oct 26, 2022 · Completed: Oct 26, 2057
3 conditions1 sponsor2 locations
NCT05608148
Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors
PHASE1Recruiting
56 participants
Started: Oct 26, 2022 · Completed: Aug 25, 2027
2 conditions1 sponsor1 location